Anticonvulsants are medicinal agents used to treat epileptic seizures. These are commonly known as anti-epileptic drugs or anti-seizure drugs. Epilepsy is a chronic central nervous system (neurological) disorder in which brain function is abnormal, leading to seizures or abnormal behavior, loss of sensation, and sometimes awareness. Anticonvulsant drugs are also used to treat bipolar disorder, borderline personality disorder, fibromyalgia, and neuropathic pain. Epilepsy can affect anyone at any age. According to data from the Epilepsy Society of UK 2019, there are more than 20 drugs available for the treatment of epilepsy, such as barbiturates, carboxamides, carbamates and GABA analogs, and around 25 generic drugs are on the market.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2516
Global Anticonvulsants Market: Drivers
The size of the anticonvulsants market is expected to increase in the forecast period due to the increasing prevalence of epilepsy globally. According to a January 2019 report by the World Health Organization (WHO), about 50 million people worldwide suffer from epilepsy. Furthermore, it is estimated that approximately 2.4 million new epilepsy cases are diagnosed worldwide each year.
Increasing approval of anticonvulsant drugs by the U.S. Food and Drug Administration (FDA) is contributing significantly to drive growth of the global anticonvulsants market revenue. There are about 24 anticonvulsant drugs approved by the FDA. In 2018, the FDA approved the first drug containing the active ingredient made from marijuana to treat rare, severe forms of epilepsy, such as Lennox-Gastaut syndrome and Dravet syndrome.
Global Anticonvulsants Market: Restraints
Fever and abnormal infections, abdominal pain and tenderness, excessive bleeding from wounds, ulcers or blisters, and mouth sores are some side effects of anticonvulsant drugs, which are the major preventive factors for the growth of the global anticonvulsants market. According to a 2013 Epilepsy Foundation report, there are some unexpected side effects known as idiosyncratic side effects that can be fatal, including a severe decrease in the number of white blood cells and platelets in the body, aplastic anaemia and liver failure.
Global Anticonvulsants Market: Regional Analysis
Due to the growing demand for epilepsy treatments, North America is expected to dominate the anticonvulsants market in the foreseeable future. For example, according to a WHO 2019 report, in 70% of people worldwide suffering from epilepsy, seizures are controlled with proper diagnosis and use of anti-epileptic drugs. There are low cost treatments available with daily medications that cost US$5 per year.
The growing prevalence of epilepsy in economies such as India, China and Japan are expected to lead to a significant growth in Asia Pacific anticonvulsants market earnings over the estimated period. According to a 2015 report by the National Center for Biotechnology Information, 12 million people in India suffer from epilepsy.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2516
Global Anticonvulsants Market: Segmentation
On the basis of Drug Class, the Global Anticonvulsants Market is segmented into:
- Succinimides
- Hydantoins
- Benzodiazepines
- Barbiturates
- Others
On the basis of Application, the Global Anticonvulsants Market is segmented into:
- Bipolar Disorder
- Anxiety
- Neuropathic Pain
- Fibromyalgia
- Migraine
- Epilepsy
On the basis of Route of Administration, the Global Anticonvulsants Market is segmented into:
- Topical
- Parenteral
- Enteral
On the basis of Distribution Channel, the Global Anticonvulsants Market is segmented into:
- Online Pharmacy
- Hospital Pharmacy
- Retail Pharmacy
On the basis of Region, the Global Anticonvulsants Market is segmented into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Global Anticonvulsants Market: Competitive Landscape
Key players performing in the global anticonvulsants market are Astrazeneca Plc, Cephalon Inc., GlaxoSmithKline Plc., Shire Plc., UCB Group, Sanofi S.A., Valeant Pharmaceuticals International, Inc., Pfizer Inc., Novartis AG, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., and Abbott Laboratories.
𝗕𝘂𝘆 𝗡𝗼𝘄 𝗧𝗼 𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 30% 𝗢𝗳𝗳
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2516
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Anticonvulsants Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Anticonvulsants Industry Impact
Chapter 2 Global Anticonvulsants Competition by Types, Applications, and Top Regions and Countries
2.1 Global Anticonvulsants (Volume and Value) by Type
2.3 Global Anticonvulsants (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Anticonvulsants Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Anticonvulsants Market Analysis
Chapter 6 East Asia Anticonvulsants Market Analysis
Chapter 7 Europe Anticonvulsants Market Analysis
Chapter 8 South Asia Anticonvulsants Market Analysis
Chapter 9 Southeast Asia Anticonvulsants Market Analysis
Chapter 10 Middle East Anticonvulsants Market Analysis
Chapter 11 Africa Anticonvulsants Market Analysis
Chapter 12 Oceania Anticonvulsants Market Analysis
Chapter 13 South America Anticonvulsants Market Analysis
Chapter 14 Company Profiles and Key Figures in Anticonvulsants Business
Chapter 15 Global Anticonvulsants Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837